Impact of Proteinuria on Renal Outcomes in the BALANCE Trial
Eric Wallace, C. Wanner, Giovanni Piotti, David Lee et autres
0 citationsKidney International Reports
Ankit Mehta
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
77Publications signalées
1585Citations signalées
4Affiliations récentes
Institutions déclarées
Domaines associés
Potassium and Related DisordersLysosomal Storage Disorders ResearchElectrolyte and hormonal disordersDiabetes Treatment and ManagementAcute Kidney Injury Research
Publications récentes
Longitudinal analysis of usage and public awareness of tyrosine kinase inhibitors for CML
Adrian E. Schroer, Tiffany Javadi, Ankit Mehta, Furkan Torlak et autres
0 citationsFrontiers in Oncology
Unbiased self supervised learning of kidney histology reveals phenotypic and prognostic insights
Krutika Pandit, Nicolas Coudray, Adalberto Claudio Quiros, Aditya Surapaneni et autres
0 citationsScientific Reports
Case Series of Proteinuria Reduction with Sparsentan (SPAR) Combined with SGLT2 Inhibitors (SGLT2is) in Adults with IgAN at a Single Site
Ankit Mehta, G Sánchez, Alexandra R. Willcockson, A. Jay Block
0 citationsJournal of the American Society of Nephrology
Vonafexor in Progressive Alport Syndrome: Early Evidence of Kidney Function Benefit from the ALPESTRIA-1 Trial
Bertrand Knebelmann, Víctor Jiménez, Arnold L. Silva, Ankit Mehta et autres
0 citationsJournal of the American Society of Nephrology
Ventricular tachycardia in end-stage kidney disease
0 citationsBaylor University Medical Center Proceedings
Rapid and Simultaneous Initiation of Guideline-Directed Kidney Therapies in Patients with CKD and Type 2 Diabetes
Ahmed Mustafa Rashid, Muhammad Shahzeb Khan, David Z.I. Cherney, Ankit Mehta et autres
19 citationsJournal of the American Society of Nephrology
Transvenous biopsy of abdominal-pelvic lesions with no safe percutaneous access: How we do it
Akhilesh Pillai, Achintya Patel, Ankit Mehta, Moaz M. Choudhary
0 citationsTechniques in vascular and interventional radiology
Extending the interval between pegunigalsidase alfa infusions in patients with Fabry disease: Five-year interim results from the ongoing BRIGHT51 study
John Bernat, Myrl Holida, Stephen Waldek, William R. Wilcox et autres
0 citationsMolecular Genetics and Metabolism
P236: Extending the interval between pegunigalsidase alfa infusions in patients with Fabry disease: Five-year interim results from the ongoing BRIGHT51 study
John Bernat, Myrl Holida, Stephen Waldek, William Wilcox et autres
0 citationsGenetics in Medicine Open
Cardiovascular mortality with oral potassium-binders in patients with CKD and heart failure
Hasti Barzkar, Brittany Miles, Ankit Mehta
0 citationsEuropean Heart Journal
The potential impact of bisphosphonates on major adverse cardiovascular events: a study of 1,097,406 patients
Khaled Atieh, Brittany Miles, John R. Mackey, Ankit Mehta
3 citationsEuropean Heart Journal
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.